Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Food and Drug Administration Updated 503A bulk drug substances list (Category 2 revision, effective April 22, 2026)
Semaglutide and cardiovascular outcomes in patients with Type 2 Diabetes
Semaglutide is a relatively new weight loss medication compared to other prescription drugs
Our compounded tirzepatide injections deliver this advanced medication directly into your system, offering a clinically supported approach to medical weight loss
To our knowledge, no study assessed the potential of abuse of these medications anecdotally reported in anorexia or bulimia nervosa, which would require further investigation
US$ 23.93
US$ 21.69
US$ 29.35
US$ 27.37
US$ 22.61
